Ryvu Therapeutics Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 24, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	615	890	1,329	1,139	1,120	903
Market Cap Growth	-4.49%	-33.04%	16.75%	1.70%	23.98%	25.66%
Enterprise Value	574	724	1,082	1,098	1,035	747
Last Close Price	26.60	38.50	57.50	49.25	61.00	49.20
PS Ratio	6.80	8.73	19.76	16.64	31.62	24.44
PB Ratio	8.63	6.19	5.12	3.32	6.94	4.04
P/TBV Ratio	9.58	6.56	5.25	3.36	7.08	4.08
P/FCF Ratio	-	-	-	75.58	-	-
P/OCF Ratio	-	-	-	53.41	-	-
PEG Ratio	-	3.41	3.41	3.41	3.41	3.41
EV/Sales Ratio	6.34	7.10	16.08	16.05	29.21	20.22
EV/FCF Ratio	-4.93	-	-	72.90	-	-
Debt / Equity Ratio	1.34	0.77	0.04	0.04	0.08	0.03
Debt / FCF Ratio	-	-	-	0.84	-	-
Net Debt / Equity Ratio	-0.58	-0.80	-0.86	-0.26	-0.46	-0.69
Net Debt / EBITDA Ratio	0.37	1.03	2.56	1.54	1.11	5.88
Net Debt / FCF Ratio	0.36	0.85	2.40	-5.96	1.06	3.43
Asset Turnover	0.28	0.26	0.15	0.19	0.14	0.15
Inventory Turnover	10.02	11.77	9.06	9.37	7.56	5.37
Quick Ratio	2.16	2.34	3.82	8.09	2.76	5.00
Current Ratio	2.27	2.52	3.99	8.21	2.88	5.10
Return on Equity (ROE)	-95.34%	-55.24%	-30.55%	-33.20%	-41.08%	-18.41%
Return on Assets (ROA)	-23.11%	-19.50%	-13.86%	-12.34%	-18.80%	-9.31%
Return on Invested Capital (ROIC)	-45.46%	-380.19%	-67.32%	-40.89%	-101.00%	-55.95%
Return on Capital Employed (ROCE)	-66.30%	-45.00%	-29.20%	-16.20%	-41.00%	-13.60%
Earnings Yield	-19.30%	-12.52%	-6.93%	-7.36%	-7.06%	-3.51%
FCF Yield	-18.92%	-15.21%	-7.00%	1.32%	-6.33%	-4.96%
Buyback Yield / Dilution	0.00%	-0.97%	-24.75%	-	-9.48%	-4.98%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.